Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells ; volume:13 ; number:1 ; day:8 ; month:12 ; year:2023 ; pages:1-14 ; date:12.2023
Scientific reports ; 13, Heft 1 (8.12.2023), 1-14, 12.2023
- Creator
-
Lei, Ming
Zhang, Yun-Long
Huang, Feng-Ying
Chen, Heng-Yu
Chen, Ming-Hui
Wu, Ri-Hong
Dai, Shu-Zhen
He, Gui-Sheng
Tan, Guang-Hong
Zheng, Wu-Ping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-49136-8
- URN
-
urn:nbn:de:101:1-2024022614321953891290
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lei, Ming
- Zhang, Yun-Long
- Huang, Feng-Ying
- Chen, Heng-Yu
- Chen, Ming-Hui
- Wu, Ri-Hong
- Dai, Shu-Zhen
- He, Gui-Sheng
- Tan, Guang-Hong
- Zheng, Wu-Ping
- SpringerLink (Online service)
Other Objects (12)
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4-independent ferroptosis—a new strategy in disease’s therapy
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4-independent ferroptosis—a new strategy in disease’s therapy
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Coculture with macrophages alters ferroptosis susceptibility of triple-negative cancer cells
DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis
GPX4-independent ferroptosis—a new strategy in disease’s therapy
GPX4 restricts ferroptosis of NKp46+ILC3s to control intestinal inflammation
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites
Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis
HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells